Medistep Health Stock Price Today (NSE: MEDISTEP)
Fundamental Score
Medistep Health Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Medistep Health share price today is ₹18.70, down 1.58% on NSE/BSE as of 23 June 2026. Medistep Health (MEDISTEP) is a Small-cap company in the Personal Care sector with a market capitalisation of ₹35.52 (Cr). The 52-week high for MEDISTEP share price is ₹30.00 and the 52-week low is ₹17.20. At a P/E ratio of 6.54x, MEDISTEP is currently trading below its industry average P/E of 50.39x. The company has a Return on Equity (ROE) of 29.02% and a debt-to-equity ratio of 0.02.
Medistep Health Share Price Chart — NSE/BSE Historical Performance
Medistep Health share price chart: -4.76% return over the past month. 52-week high ₹30.00, 52-week low ₹17.20.
Medistep Health — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹17.60 | ₹19.90 | ₹17.60 | ₹18.70 | 27.00K (Cr) | |
| ₹19.00 | ₹19.00 | ₹19.00 | ₹19.00 | 3.00K (Cr) | |
| ₹17.40 | ₹21.00 | ₹17.40 | ₹18.20 | 9.00K (Cr) | |
| ₹21.80 | ₹21.80 | ₹21.80 | ₹21.80 | 9.00K (Cr) | |
| ₹22.95 | ₹22.95 | ₹22.90 | ₹22.90 | 9.00K (Cr) | |
| ₹22.05 | ₹22.05 | ₹22.05 | ₹22.05 | 6.00K (Cr) | |
| ₹22.00 | ₹22.00 | ₹21.00 | ₹21.00 | 9.00K (Cr) | |
| ₹21.90 | ₹21.90 | ₹21.90 | ₹21.90 | 3.00K (Cr) | |
| ₹19.95 | ₹19.95 | ₹19.95 | ₹19.95 | 6.00K (Cr) | |
| ₹17.25 | ₹17.30 | ₹17.20 | ₹17.20 | 9.00K (Cr) |
Medistep Health — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹17.60 | ₹19.90 | ₹17.60 | ₹18.70 | +6.25% | |
| ₹22.00 | ₹22.95 | ₹17.40 | ₹19.00 | -13.64% | |
| ₹17.25 | ₹21.90 | ₹17.20 | ₹21.90 | +26.96% | |
| ₹19.00 | ₹19.00 | ₹17.20 | ₹17.35 | -8.68% | |
| ₹22.75 | ₹24.00 | ₹21.00 | ₹23.70 | +4.18% | |
| ₹25.75 | ₹29.00 | ₹22.50 | ₹22.75 | -11.65% | |
| ₹25.00 | ₹27.50 | ₹23.00 | ₹23.05 | -7.80% | |
| ₹24.10 | ₹30.00 | ₹22.30 | ₹27.00 | +12.03% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Medistep Health Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medistep Health Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDISTEP across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (29.02%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (37.83%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 6.54 vs Industry: 50.39)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (75.74%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (65.04%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.02)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (726.00x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (68.96%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medistep Health vs Personal Care Peers
Peer Comparison - Personal Care
Compare Medistep Health with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
56/100 | ₹18.70₹19 | ₹35.52₹35.52 | 6.54Average 6.5 Average | 29.02%Excellent 29.02% Excellent | 37.83%Excellent 37.83% Excellent | 0.02Excellent 0.0 Excellent | — — | — — | 0.00% | |
Godrej Consumer Products LtdGodrej Consumer... GODREJCP • 532424 | 42.9/100 | ₹1044.40₹1044 | ₹115504.75₹115504.75 | 61.35Average 61.4 Average | 15.21%Good 15.21% Good | 19.21%Good 19.21% Good | 0.34Excellent 0.3 Excellent | 3.75%Average 3.75% Average | 7.70%Good 7.70% Good | 1.33% |
Dabur India LtdDabur India Ltd... DABUR • 500096 | 45.3/100 | ₹445.45₹445 | ₹91407.05₹91407.05 | 50.53Average 50.5 Average | 17.04%Good 17.04% Good | 20.24%Excellent 20.24% Excellent | 0.12Excellent 0.1 Excellent | 3.01%Average 3.01% Average | 7.66%Good 7.66% Good | 1.55% |
Colgate Palmolive India LtdColgate Palmoli... COLPAL • 500830 | 53.3/100 | ₹2087.40₹2087 | ₹58477.58₹58477.58 | 44.10Average 44.1 Average | 81.19%Excellent 81.19% Excellent | 105.34%Excellent 105.34% Excellent | 0.04Excellent 0.0 Excellent | 11.96%Good 11.96% Good | 5.95%Good 5.95% Good | 2.37% |
Procter & Gamble Hygiene LimitedProcter & Gambl... PGHH • 500459 | 49.3/100 | ₹10115.00₹10115 | ₹41537.66₹41537.66 | 50.25Average 50.3 Average | 75.67%Excellent 75.67% Excellent | 103.79%Excellent 103.79% Excellent | 0.00Excellent 0.0 Excellent | 8.44%Good 8.44% Good | 2.75%Average 2.75% Average | 0.86% |
Gillette India LtdGillette India ... GILLETTE • 507815 | 54.7/100 | ₹8273.50₹8274 | ₹27967.94₹27967.94 | 48.73Average 48.7 Average | 41.62%Excellent 41.62% Excellent | 56.06%Excellent 56.06% Excellent | 0.00Excellent 0.0 Excellent | 10.45%Good 10.45% Good | 3.72%Average 3.72% Average | 1.31% |
Emami LtdEmami Ltd... EMAMILTD • 531162 | 57.2/100 | ₹400.45₹400 | ₹22959.79₹22959.79 | 30.46Average 30.5 Average | 30.18%Excellent 30.18% Excellent | 32.42%Excellent 32.42% Excellent | 0.02Excellent 0.0 Excellent | 21.30%Excellent 21.30% Excellent | 7.49%Good 7.49% Good | 1.52% |
Cupid LtdCupid Ltd... CUPID • 530843 | 32.5/100 | ₹128.90₹129 | ₹9372.27₹9372.27 | 151.83Average 151.8 Average | 12.89%Average 12.89% Average | 17.10%Good 17.10% Good | 0.07Excellent 0.1 Excellent | 0.89%Average 0.89% Average | 2.70%Average 2.70% Average | 0.00% |
Honasa Consumer LtdHonasa Consumer... HONASA • 544014 | 51.3/100 | ₹419.95₹420 | ₹9315.44₹9315.44 | 74.86Average 74.9 Average | 5.51%Poor 5.51% Poor | 7.44%Poor 7.44% Poor | 0.09Excellent 0.1 Excellent | 16.54%Excellent 16.54% Excellent | 76.22%Excellent 76.22% Excellent | 0.00% |
Bajaj Consumer Care LtdBajaj Consumer ... BAJAJCON • 533229 | 58.3/100 | ₹560.75₹561 | ₹3635.38₹3635.38 | 26.63Average 26.6 Average | 15.70%Good 15.70% Good | 19.06%Good 19.06% Good | 0.03Excellent 0.0 Excellent | -7.53%Poor -7.53% Poor | 2.51%Average 2.51% Average | 0.00% |
Anondita MediAnondita Medi... ANONDITA • | 33.7/100 | ₹1013.25₹1013 | ₹1191.73₹1191.73 | 51.90Average 51.9 Average | — — | — — | 0.43Excellent 0.4 Excellent | — — | — — | 0.00% |
Top Personal Care Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Godrej Consumer Products Ltd share price115504.75 Cr
- Dabur India Ltd share price91407.05 Cr
- Colgate Palmolive India Ltd share price58477.58 Cr
- Procter & Gamble Hygiene Limited share price41537.66 Cr
- Gillette India Ltd share price27967.94 Cr
Medistep Health Quarterly Performance
Latest quarterly metrics for MEDISTEP — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
65.04%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
75.74%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Medistep Health Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MEDISTEP — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Medistep Health Financial Statements
Annual income statement, balance sheet and cash flow for Medistep Health (MEDISTEP) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Medistep Health
About MEDISTEP (Medistep Health)
Medistep Health (MEDISTEP) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Personal Care sector with a current ...market capitalisation of ₹35.52 (Cr). Medistep Health has delivered a Return on Equity (ROE) of 29.02% and a ROCE of 37.83%. The debt-to-equity ratio stands at 0.02, reflecting the company's capital structure. Investors tracking MEDISTEP share price can monitor key metrics including P/E ratio, promoter holding of 68.96%, and quarterly earnings growth.
Company Details
MEDISTEP Share Price: Frequently Asked Questions
What is the current share price of Medistep Health?
Medistep Health (MEDISTEP) trades at ₹18.70 on NSE. Market cap ₹35.52 (Cr). Educational data only.
What is the P/E ratio of Medistep Health?
Medistep Health has a P/E of 6.54x vs industry average 50.39x.
What is the Bull Run score for Medistep Health?
Medistep Health has a Bull Run score of 56/100 based on 25+ financial parameters.
Does Medistep Health pay dividends?
Medistep Health has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Medistep Health?
Medistep Health has ROE of 29.02%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Medistep Health?
Medistep Health has debt-to-equity of 0.02.
Is Medistep Health a good investment?
Bull Run gives Medistep Health a score of 56/100. This is not investment advice — consult a SEBI-registered advisor.